Following the biopharmaceutical industry’s recent meeting with President Donald J. Trump, PhRMA president and CEO Stephen J. Ubl joined Dan Diamond on POLITICO’s Pulse Check podcast to discuss the future of innovation in health care and the industry’s new national advertising and public affairs campaign: GOBOLDLY™. The campaign focuses on the new era of medicine, public health and ways we can evolve our private payment and reimbursement system to be as innovative as the medicines our companies produce.
Listen to the full interview here, and visit GoBoldly.com and Innovation.org to learn more about #GOBOLDLY.
Holly Campbell Holly Campbell is a deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines. Prior to joining PhRMA, Holly worked for large and small public relations firms where she provided strategic communications counsel, media relations and partnership expertise to health care and pharmaceutical clients. In her free time, she enjoys taking barre classes, trying new restaurants and spending time with Boss and Poppy, her rescue pups.
Topics: Value-Driven Health Care, GoBoldly, The Value Collaborative
Medicare Monday (100)
340B Spotlight (41)
Cost & Consequence (0)
